Houtkooper R H, Vaz F M
Laboratory of Genetic Metabolic Diseases, University of Amsterdam, Academic Medical Center, Department of Clinical Chemistry, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands.
Cell Mol Life Sci. 2008 Aug;65(16):2493-506. doi: 10.1007/s00018-008-8030-5.
Cardiolipin is a unique phospholipid, which is almost exclusively localized in the mitochondrial inner membrane where it is synthesized from phosphatidylglycerol and cytidinediphosphate-diacylglycerol. After primary synthesis, the mature acyl chain composition of cardiolipin is achieved by at least two remodeling mechanisms. In the mitochondrial membrane cardiolipin plays an important role in energy metabolism, mainly by providing stability for the individual enzymes and enzyme complexes involved in energy production. Moreover, cardiolipin is involved in different stages of the mitochondrial apoptotic process and in mitochondrial membrane dynamics. Cardiolipin alterations have been described in various pathological conditions. Patients suffering from Barth syndrome have an altered cardiolipin homeostasis caused by a primary deficiency in cardiolipin remodeling. Alterations in cardiolipin content or composition have also been reported in more frequent diseases such as diabetes and heart failure. In this review we provide an overview of cardiolipin metabolism, function and its role in different pathological states.
心磷脂是一种独特的磷脂,几乎仅存在于线粒体内膜中,它由磷脂酰甘油和胞苷二磷酸二酰甘油合成。初次合成后,心磷脂成熟的酰基链组成至少通过两种重塑机制来实现。在心线粒体膜中,心磷脂在能量代谢中起重要作用,主要是为参与能量产生的各个酶和酶复合物提供稳定性。此外,心磷脂还参与线粒体凋亡过程的不同阶段以及线粒体膜动力学。在心磷脂在各种病理状态下的改变已有描述。患有Barth综合征的患者由于心磷脂重塑的原发性缺陷而导致心磷脂稳态改变。在诸如糖尿病和心力衰竭等更常见的疾病中也报道了心磷脂含量或组成的改变。在本综述中,我们概述了心磷脂的代谢、功能及其在不同病理状态中的作用。